Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Reference35 articles.
1. Beauregard JM, Blouin AC, Fradet V, Caron A, Fradet Y, Lemay C et al (2015) FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy. Cancer Imaging 15:2
2. Mottet N, Bellmunt J, Briers E, van den Bergh RCN, Bolla M, van Casteren NJ, Cornford P, Culine S, Joniau S, Lam T, Mason MD, Matveev V, van der Poel H, van der Kwast TH, Rouvière O, Wiegel T (2016) Guidelines on prostate cancer. European Association of Urology Web site. https://uroweb.org/guideline/prostate-cancer/ . Accessed 17 May 2016
3. Evangelista L, Guttilla A, Zattoni F, Muzzio PC, Zattoni F (2013) Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. Eur Urol 63(6):1040–1048
4. Evangelista L, Zattoni F, Guttilla A, Saladini G, Zattoni F, Colletti PM et al (2013) Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Clin Nucl Med 38(5):305–314
5. Passoni NM, Suardi N, Abdollah F, Picchio M, Giovacchini G, Messa C et al (2014) Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series. Urol Oncol 32(1):38 e9–38 e16